358 related articles for article (PubMed ID: 20838200)
1. Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.
Kalra A; Cooley C; Palaniswamy C; Kalra A; Zanotti-Cavazzoni SL
Am J Ther; 2012 Nov; 19(6):e189-92. PubMed ID: 20838200
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis.
Shino M; Takahashi K; Murata T; Iida H; Yasuoka Y; Furuya N
Am J Otolaryngol; 2011; 32(6):624-6. PubMed ID: 21324549
[TBL] [Abstract][Full Text] [Related]
4. Valsartan-induced angioedema.
Irons BK; Kumar A
Ann Pharmacother; 2003; 37(7-8):1024-7. PubMed ID: 12841812
[TBL] [Abstract][Full Text] [Related]
5. Angioedema: 6 years experience with fourteen cases.
Taki M; Watanabe H; Hasegawa T; Bamba H; Shimada T; Hisa Y
Auris Nasus Larynx; 2010 Apr; 37(2):199-204. PubMed ID: 19709832
[TBL] [Abstract][Full Text] [Related]
6. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Malde B; Regalado J; Greenberger PA
Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
[TBL] [Abstract][Full Text] [Related]
7. Valsartan in chronic heart failure.
Ripley TL
Ann Pharmacother; 2005 Mar; 39(3):460-9. PubMed ID: 15687480
[TBL] [Abstract][Full Text] [Related]
8. Angioedema and photosensitive rash induced by valsartan.
Frye CB; Pettigrew TJ
Pharmacotherapy; 1998; 18(4):866-8. PubMed ID: 9692664
[TBL] [Abstract][Full Text] [Related]
9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan medoxomil-induced angioedema.
Nykamp D; Winter EE
Ann Pharmacother; 2007 Mar; 41(3):518-20. PubMed ID: 17341528
[TBL] [Abstract][Full Text] [Related]
11. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
[TBL] [Abstract][Full Text] [Related]
12. Valsartan, captopril, or both in myocardial infarction.
Jorde UP
N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988936
[No Abstract] [Full Text] [Related]
13. Valsartan, captopril, or both in myocardial infarction.
Moshenyat R; Kupfer Y; Tessler S
N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988935
[No Abstract] [Full Text] [Related]
14. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
15. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
17. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers].
Roskiewicz F; Andriamanana I; Gras-Champel V; Andrejak M; Massy ZA
Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Zhu S; Liu Y; Wang L; Meng QH
Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
[TBL] [Abstract][Full Text] [Related]
19. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
Chiu AG; Krowiak EJ; Deeb ZE
Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
[TBL] [Abstract][Full Text] [Related]
20. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ; Dunn SP; Macaulay TE
Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]